The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma (HL): North American results.
 
Rod Ramchandren
Consulting or Advisory Role - Seagen
Research Funding - Seagen
 
Ranjana H. Advani
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Cell Medica; Genentech/Roche; Gilead Sciences; NanoString Technologies; Pharmacyclics; Seagen; Spectrum Pharmaceuticals; Sutter Medical Group
Research Funding - Agensys (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Kura Oncology (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Regeneron (Inst); Seagen (Inst)
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst)
 
Nancy L. Bartlett
Consulting or Advisory Role - Kite, a Gilead company; Pfizer; Seagen
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dynavax Technologies (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); Idera (Inst); Immune Design (Inst); Incyte (Inst); Janssen (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Robert W. Chen
Honoraria - Genentech/Roche; Merck; Millennium; Seagen
Consulting or Advisory Role - Genentech/Roche; Merck; Seagen
Speakers' Bureau - Genentech/Roche; Millennium; Seagen
Research Funding - Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Merck; Seagen
 
Tatyana Feldman
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb; Kite, a Gilead company; Pharmacyclics/Janssen; Seagen
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Seagen
Speakers' Bureau - Abbvie; Kite, a Gilead company; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Viracta Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Kite, a Gilead company; Pharmacyclics; Seagen
 
Andres Forero-Torres
Speakers' Bureau - Seagen
Research Funding - Seagen
 
Jonathan W. Friedberg
Consulting or Advisory Role - Bayer
Research Funding - Kite, a Gilead company (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Roche
 
Ajay K. Gopal
Honoraria - Sanofi/Aventis; Seagen; Takeda
Consulting or Advisory Role - Pfizer; Sanofi/Aventis; Seagen
Research Funding - Biogen; Biomarin; Cephalon; Emergent BioSolutions; Gilead Sciences; Janssen; Merck; Pfizer; Piramal Life Science; Seagen; Spectrum Pharmaceuticals; Takeda
 
Leo I. Gordon
Patents, Royalties, Other Intellectual Property - Zylem
Other Relationship - Gilead Sciences
 
John Kuruvilla
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Kaleo; Merck; Roche; Seagen
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck; Roche; Seagen
Research Funding - Janssen; Roche
 
Kerry J. Savage
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck; Novartis; Seagen; Servier
Research Funding - Roche (Inst)
 
David J. Straus
Travel, Accommodations, Expenses - Takeda
 
Anas Younes
Honoraria - Abbvie; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck; Roche; Takeda
Consulting or Advisory Role - Asana Biosciences; Bayer; Bristol-Myers Squibb; Genentech/Roche; Gilead Sciences; Incyte; Janssen; Merck; Seagen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Curis (Inst); Janssen (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Keenan Fenton
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Thomas John Manley
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Gerald Engley
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Joseph M. Connors
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cephalon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Roche (Inst); Seagen (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Evaluation of mantle cell lymphoma and methods related thereof (Inst); Methods for selecting and treating lymphoma types (Inst)